Revvity (LTS:0KHE) FFO


LTS:0KHE Revvity Inc LTS:0KHE
75 GF Score
Price $113.85
GF Value $120.38
Valuation Fairly Valued
! 11 Warning Signs
View Full Analysis

What is Revvity FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0KHE
75GF Score
Revvity Inc LTS:0KHE
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Revvity (LTS:0KHE) Overvalued in 2026?

Based on GuruFocus' analysis, Revvity stock appears to be undervalued. The current stock price of $113.85 is trading 5.4% below its estimated GF Value™ of $120.38. GuruFocus considers Revvity to be Fairly Valued.

Key valuation signals for LTS:0KHE:

  • FFO:
  • GF Value™: $120.38 vs. price of $113.85 (5.4% below fair value)
  • GF Score™: 75/100 with 11 warning signs

No single metric tells the full story. See the LTS:0KHE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Revvity Business Description

Address 77 4th Avenue, Waltham, MA, USA, 02451
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
75GF Score

Get the complete analysis for LTS:0KHE

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$113.85
Price
$120.38
GF Value